Cerevel Therapeutics Hldg Inc (CERE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
| Operating Expenses | 142,656 | 139,564 | 111,307 | 96,843 | 99,551 |
| Operating Income | -142,656 | -139,564 | -111,307 | -96,843 | -99,551 |
| Interest Expense | 2,652 | 2,647 | 2,644 | 2,640 | 2,636 |
| Other Income | 13,534 | 9,739 | 17,713 | 55 | -2,014 |
| Pre-tax Income | -131,774 | -132,472 | -96,238 | -99,428 | -104,201 |
| Income Tax | 138 | 188 | 123 | 107 | 85 |
| Net Income Continuous | -131,912 | -132,660 | -96,361 | -99,535 | -104,286 |
| Net Income | $-131,912 | $-132,660 | $-96,361 | $-99,535 | $-104,286 |
| EPS Basic Total Ops | -0.73 | -0.76 | -0.61 | -0.63 | -0.67 |
| EPS Basic Continuous Ops | -0.73 | -0.76 | -0.61 | -0.63 | -0.67 |
| EPS Diluted Total Ops | -0.73 | -0.76 | -0.61 | -0.63 | -0.67 |
| EPS Diluted Continuous Ops | -0.73 | -0.76 | -0.61 | -0.63 | -0.67 |
| EPS Diluted Before Non-Recurring Items | -0.73 | -0.76 | -0.61 | -0.63 | -0.67 |
| EBITDA(a) | $-147,241 | $-143,585 | $-114,356 | $-99,961 | $-103,436 |